Articles

Article

The Psychedelic Syndicate: Part 4

Part 4 of The Psychedelic Syndicate reveals PSFC’s strategy to manufacture spiritual and moral authority through academic capture — even as some members align with far-right ideologies that deepen the very crises psychedelics are meant to heal.

Article

The Psychedelic Syndicate: Part 3

Part 3 of The Psychedelic Syndicate exposes how Silicon Valley’s “move fast and break things” mentality infected psychedelic therapy, creating a culture where leaders rationalized patient harm as unavoidable for progress and ultimately embraced Trump administration officials who promised regulatory

Article

The Psychedelic Syndicate: Part 2

Part 2 of The Psychedelic Syndicate exposes the compromised foundation of PSFC’s influence network — from the abuse scandals that undermined their preferred therapy model, to undisclosed ties with the sole FDA advisory committee member who voted unequivocally for MDMA approval.

Article

The Psychedelic Syndicate: Part 1

Part 1 of The Psychedelic Syndicate reveals how the Psychedelic Science Funders Collaborative (PSFC) — a wealthy network of Silicon Valley elites and Burning Man devotees — systematically captured the psychedelic movement by influencing MAPS, funding its subsidiary Lykos’ MDMA clinical trials, and p

Article

Correcting the Record: Addressing The New York Times’ Deceptive Coverage of Psymposia

Rather than unpacking the actual causes of Lykos Therapeutics’ disastrous Phase 3 trials and FDA rejection, The New York Times produced a work of fictitious propaganda that prioritizes corporate interests over public health.

Article

Correcting the Record: What The New York Times Got Wrong

In response to The New York Times February 4 article, “How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy,” Psymposia requested corrections to numerous errors and false accusations.

Article

Psymposia’s Response to Heroic Hearts’ Pharma-Backed Press Conference

Veterans deserve the highest quality treatment for PTSD. It’s unacceptable and dangerous to use veterans as guinea pigs for a big pharma profit grab without resolving safety and efficacy concerns.

Article

Every Disclosed Conflict of Interest at Psychedelic Science 2023

All the financial conflict disclosures from Psychedelics Science 2023 speakers, in one handy list.

Article

Psychedelic Science 2023 Contract Muzzles Speakers: Two Clauses Dictate What Presenters Can and Can’t Say

In order to present at Psychedelic Science 2023, speakers must agree to two out-of-the-ordinary requests about content exclusivity and MAPS’ reputation.

Article

Church of Psilomethoxin, Part 4: The Church That Cried Capitalism

The Church of Psilomethoxin claims it’s the victim of “psychedelic capitalism,” but almost everything it claims is wrong.

Article

Church of Psilomethoxin, Part 3: Matters of Faith. Father, Son, and Wholly Dosed?

The Church of Psilomethoxin now admits that its claims about psilomethoxin are solely based on faith. But how strong are the religious convictions of the Church?

Article

The Church of Psilomethoxin Part 2: Unraveling the Sacred Chemistry

Psymposia’s investigation into the Church of Psilomethoxin (CoP) turns to the Church’s claims that it’s currently “scientifically impossible” to test for psilomethoxin. Psychedelic chemist David Nichols calls that claim “completely nonsensical and nonscientific.